Ledger.Open graph →
SEC Form D · filed December 8, 2015

Clearside Biomedical, Inc

Offering
$20.0M
Sold
$14.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Alpharetta, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Clay N. Thorp · Durham, NCDirectorChristy H. Shaffer · Durham, NCDirectorWilliam D. Humphries · Greensboro, NCDirectorEvgeny D. Zaytsev · Palo Alto, CADirectorGerald D. Cagle · Fort Worth, TXDirectorFarrell M. Ender · Philadelphia, PADirectorScott F. Schaeffer · Philadelphia, PADirectorWilliam C. Dunkelberg · Philadelphia, PADirectorJames J. Sebra · Philadelphia, PADirectorCharlie D. Deignan · Alpharetta, GAExecDaniel White · Alpharetta, GAExec · Director · PromoterMukesh K. Parekh · SANTA MONICA, CADirectorNate K. Redmond · SANTA MONICA, CADirectorNick Grouf · SANTA MONICA, CADirectorRichard Lowenthal · Campbell, CADirectorCharlie D. Deignan · Alpharetta, GAExecEvgeny D. Zaytsev · Palo Alto, CADirectorDaniel White · Alpharetta, GAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗